Noteworthy Tuesday Option Activity: TMUS, FANG, OSCR

Diamondback Energy (FANG) saw 7,869 options contracts trade today — about 786,900 underlying shares, equal to roughly 41.7% of its one‑month average daily volume (1.9M shares) — led by 2,774 contracts in the $175 call expiring Feb. 20, 2026 (≈277,400 shares). Oscar Health (OSCR) registered 33,119 contracts (~3.3M underlying shares), about 41.1% of its one‑month average daily volume (8.0M shares), with the $18 call expiring Mar. 20, 2026 accounting for 3,233 contracts (~323,300 shares). The flows point to concentrated call activity in both names that could signal directional positioning or speculative bets ahead of future catalysts.

Analysis

Market structure: Large call prints in FANG (2,774 Feb‑2026 $175 calls ≈277.4k shares) and OSCR (3,233 Mar‑2026 $18 calls ≈323.3k shares) represent concentrated upside demand equal to ~41% of each name’s ADV — strong directional positioning that benefits long-delta holders and market makers collecting premium via spreads. Dealers will delta‑hedge, creating incremental buy pressure in the underlying on upticks and exacerbating short‑term momentum; energy peers and insurer comparables will likely see correlated flows if these names run. Options-driven demand signals asymmetric appetite for upside rather than broad fundamental rotation, so immediate supply/demand is liquidity‑driven, not inventory‑constrained production or underwriting changes.

Risk assessment: Tail risks differ: FANG is exposed to a commodity shock (WTI drop >20% within 3 months) that would wipe >30% off E&P cash flow; OSCR faces policy/regulatory shifts to Medicaid/ACA that could compress margins >200–300 bps over a year. Time horizons matter: days–weeks see dealer gamma/dealer flow impact; months–quarter see earnings, oil price and enrollment cycles; 12+ months revert to fundamentals (production profiles, loss ratios). Hidden dependency: heavy call volume may be spreads or buy‑writes — net vega may be muted; second‑order effect is increased cross‑ticker correlation and implied vol term‑structure steepening ahead of expiries.

Trade implications: Take small, defined‑risk positions: for FANG consider a 1–2% portfolio equivalent via Feb‑20‑2026 $175–$195 call spread (debit) sized to lose <1% if IV collapses, target 50–100% premium return or close if FANG >$215; alternatively 2% long equity with 15% stop. For OSCR, consider a Mar‑20‑2026 $18–$24 call spread (0.5–1% portfolio) to capture upside while limiting vega; pair trade: long FANG / short XLE (0.5x notional) to extract stock‑specific upside vs broad energy. Enter within 2 weeks while flow persists; exit on 30–50% realized move or IV spike >40% vs entry.

Key Decisions for Investors

• Establish a capped‑risk bullish position in FANG: buy a Feb‑20‑2026 $175–$195 call spread sized to 1–2% of portfolio; set option loss limit at 100% of premium and take profits at 50–100% premium gain or if FANG > $215 (whichever earlier).
• Establish a tactical long in OSCR using a Mar‑20‑2026 $18–$24 call spread equal to 0.5–1% portfolio; close if OSCR rises >30% from entry or if implied volatility increases by >40% versus entry (convert to stock hold only if fundamentals justify).
• Implement a relative value pair: long FANG vs short XLE at 0.5x notional to isolate company‑specific upside; size net exposure to 1–1.5% portfolio and unwind within 2–8 weeks if spread narrows <5% or FANG underperforms XLE by >10%.
• Do NOT chase naked calls; instead monitor option‑implied flow: if daily call volume stays >30% of ADV for 2 consecutive weeks, incrementally add (up to +0.5% portfolio) to call‑spread positions; cut exposure if WTI drops >20% in 30 days or if regulatory headlines on ACA/Medicaid affect OSCR within 60 days.